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ABSTRACT
Objective: The aim of this study was to translate the Satisfaction with
Information about Medicines Scale (SIMS) into German and test its psy-
chometric properties in a German primary care setting. The SIMS was
developed to assess the extent to which patients feel they have received
enough information about their medicines.
Methods: Three hundred seventy chronically ill patients were included in
the study. The SIMS was translated to SIMS-D (German version) and
evaluated in terms of acceptability, internal consistency, test–retest reli-
ability, discriminant, and criterion-related validity.
Results: The SIMS-D showed good internal consistency (Cronbach’s a
0.92) and adequate test–retest reliability (Pearson’s r > 0.7). Relationships
to external criteria regarding medication management were acceptable
(Spearman’s r > 0.4). The SIMS-D was reasonably well accepted (return
rate of 71%); however, older people produced more missing values when
ﬁlling in the questionnaire.
Conclusions: Preliminary evidence was given that the SIMS-D is a suitable
instrument for measuring patient satisfaction with information about
medicines in German primary care settings.
Keywords: medicines information, patient satisfaction, psychometric
properties, questionnaire.
Introduction
Information on medication plays an important role in the reliable
and correct usage of prescribed medications and thus in the
successful treatment of diseases [1], but low adherence is a ubiq-
uitous problem with adherence rates of only about 50% for
chronic medications [2]. Patient satisfaction is a multifaceted
construct [3] that, among many other factors, directly inﬂuences
adherence [4]. It appears to be important that the information
given meets the patient’s individual needs to improve patient
satisfaction [1]. Nevertheless, essential issues from a physician’s
point of view do not necessarily correspond to what an indi-
vidual patient requires to make an informed choice about the
treatment and to be able to use the medication to best effect.
Because information needs and preference vary between indi-
viduals, the ﬁnal arbiter on the quality of information is the
individual patient [5].
The “Satisfaction with Information about Medicines Scale”
(SIMS) is a questionnaire developed to measure the patients’
satisfaction with information provided by caregivers (SIMS and
SIMS-D [German version], copyright of Robert Horne, Univer-
sity of London). It is a method of eliciting patients’ views on
medication information rather than deﬁning the absolute quan-
tity or quality of the information obtained. The SIMS therefore
identiﬁes unmet medicine information needs from the perspective
of the individual patient [5]. The SIMS has been used in several
studies with chronically ill patients to assess patient satisfaction
with information on medicines [6–9]. So far, a German version of
the SIMS has not been available. The aim of our study is to
examine psychometric properties of a translated and culturally
adapted version of the SIMS-D.
Methods
Subjects
The questionnaire was sent to 370 chronically ill patients par-
ticipating in a project aiming to harmonize medication commu-
nication between different health-care sectors. Inclusion criteria
for patients were long-term medication for a chronic disease,
participation in a disease management program, and expected
hospitalization in the medium-term. On enrollment in the
project, patients agreed on participating in a patient survey that
had been approved by the Ethics Committee of the Medical
Faculty of the University of Heidelberg. The questionnaire was
sent to patients once their medication had undergone a quality
check, consisting of an Internet-based knowledge database (AiD-
Praxis http://www.aidpraxis.de) checking medication interac-
tions, and a medication consultation with their GP (general
practitioner).
Measures
The following measures were used and ﬁlled in by the patient: the
SIMS-D and the “Medication Adherence Report Scale” (MARS-
D, German version). The MARS is an instrument that showed
good internal consistency in the original UK sample (Cronbach’s
a 0.67–0.90) in asthma, diabetes, and hypertension patient
groups, and good test–retest reliability (Pearson’s r = 0.97) [10].
Three questions regarding medication management in the
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patient’s general practice were added because organizational
factors are often related to patient satisfaction [4] as well as data
on the patient’s sociodemographic data: age, sex, education,
self-reported diseases, and self-reported number of medicines.
SIMS. The SIMS is composed of 17 items derived from the
recommendations of the Association of the British Pharmaceuti-
cal Industry. These specify the type of information that patients
need for safe and accurate self-management of medication.
Patients are asked to rate the medicine information they have
received on a 5-point scale: “too much,” “about right,” “too
little,” “none received,” and “none needed.” The SIMS was
translated into German (SIMS-D) according to the guidelines for
translation and cultural adaptation of patient-reported outcome
measures [10,11], which has been published elsewhere [12]. Shu-
man’s random mode method was used to ensure that items and
response choices were well understood and were equivalent to
the original [13].
Responses of the items of the SIMS-D were coded analog
to the English version: “too much,” “too little,” and “none
received” were coded 0; “about right” and “none needed” were
coded 1. A total score of all items was calculated ranging from 0
to 17 for overall satisfaction with information received; higher
scores indicated a higher degree of total satisfaction. Summing
items 1 to 9 (subscale 1) identiﬁed satisfaction with information
about “action and usage of medication” (scores ranging from 0
to 9); items 10 to 17 (subscale 2) identiﬁed satisfaction with
information about “potential problems of medication” (scores
ranging from 0 to 8).
MARS-D. Self-report of adherence to medication was assessed
using ﬁve questions with response alternatives that captured
various dimensions of nonadherence ranging from “always”
(scored 1) to “never” (scored 5). Scores ranging from 5 to 25
were calculated; higher scores indicated higher adherence.
Medication management. Medication management was assessed
by asking if the patient had received a prescription medication
plan from his or her physician (yes/no), if the physician usually
inquired about further medication being taken, and if he or she
asked whether the medication prescribed was being tolerated,
using ﬁve response alternatives ranging from “always” to”
never.”
Statistical Analysis
The software SPSS (version 15.0) (SPSS Inc., Chicago, IL) was
used for statistical analyses. Because of skewed data distribution,
nonparametric tests were performed for all correlations except
for test–retest reliability to allow comparison with the original
data.
Item descriptive. Descriptive analyses were performed to assess
the frequencies for each item; mean, median, and standard devia-
tion were calculated for the scores; ceiling and ﬂoor effects were
explored. Acceptability and handling of the instrument were
judged by the response rate and by evaluating questionnaires
with missing items. Signiﬁcant differences in sociodemographic
data between patients sending back complete and incomplete
questionnaires as well as differences in responders and nonre-
sponders were analyzed using chi-square test and Mann–
Whitney U test.
Reliability. Cronbach’s a was used to estimate internal consis-
tency at baseline to allow comparison with original data (results
of the original data set are demonstrated in Table 2). Interitem
correlation was assessed by computing bivariate correlations
using Spearman’s r.
Test–retest reliability was assessed using a prospective
follow-up sample computing Pearson’s correlation coefﬁcient r.
The SIMS-D was sent to the ﬁrst 50 patients to send back their
questionnaire. This occurred 4 weeks after the initial round,
requesting help for quality assurance of the instrument. One
question was added at the end of the questionnaire asking if
medication counseling by a physician or physician assistant had
taken place since completing the last questionnaire. This proce-
dure produced two groups. Group A was composed of patients
who had not experienced counseling. These were included for
test–retest. Group B was composed of patients who had a coun-
seling session in between the ﬁrst and the second measurement.
Assuming that medication counseling has an impact on patient
satisfaction with information on medicines and thus on the sta-
bility of the instrument, group B was excluded for test–retest but
used in a second step to demonstrate discriminant validity. Dis-
criminant validity was assessed by describing the difference in
mean scores (D) between the ﬁrst and the second measurement in
patients with and without counseling. Because of the small
sample size, no signiﬁcance testing was performed.
Validity. Spearman’s correlation coefﬁcient r between subscale 2
(“potential problems of medication”) and two questions regard-
ing medication management in the practice was computed
for criterion-related validity. Analog to the English validation
process, correlation between MARS-D, and SIMS-D scores were
computed to investigate the relationship between satisfaction
with information and self-reported adherence using Spearman’s
r (original study r = 0.31, P < 0.05).
Results
In total, 264 of the 370 administered questionnaires were
returned (71%). Excluding questionnaires with missing data,
212 questionnaires with complete SIMS-D (57%) could be
analyzed. Table 1 displays characteristics of the study sample.
Demonstration of item frequencies can be found at http://www.
ispor.org/Publications/value/ViHsupplementary/ViH12i8_
Mahler.asp.
Acceptability and Handling of the Instrument
There was no difference between responders and nonresponders
regarding age (Mann–Whitney U test: Z = -0.22; P = 0.83) and
sex (chi-square(1) = 0.52; P = 0.47). Patients who left out items
(n = 52) were signiﬁcantly older than patients who completed
the whole questionnaire (n = 212) (mean = 72.7 years vs.
mean = 68.3 years; Z = -2.42; P = 0.01). No signiﬁcant differ-
ence was detected among other sociodemographic factors:
sex (chi-square(1) = 0.46; P = 0.50), mother tongue (chi-
square(1) = 2.31; P = 0.13), number of diseases (Z = -1.80;
P = 0.07), or number of medicines (Z = -0.56; P = 0.58).
The descriptive values of the scores obtained are displayed in
Table 2. Substantial ceiling effects are demonstrated in all scores
showing highest satisfaction in nearly 40% on the “action and
usage” subscale. Considerable ﬂoor effects occurred on the sub-
scale “potential problems of medication” (13.2%).
Internal Consistency and Test–Retest Reliability
At baseline, the internal consistency for the whole SIMS-D and
subscales 1 and 2 showed values of 0.92, 0.87 and 0.90, respec-
tively. Interitem correlations were acceptable (Table 2).
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Forty questionnaires (80%) were returned in the retest
sample, of which 30 (60%) were complete (including informa-
tion about medication counseling in the meantime). Test–retest
reliability of the SIMS-D in group A was adequate (Pearson’s
r > 0.7).
Assessing Criterion-Related Validity
The analysis of correlations between SIMS-D and additional
questions regarding medication management revealed
r-values > 0.43 for subscale 2. These can be found in Table 2
at http://www.ispor.org/Publications/value/ViHsupplementary/
ViH12i8_Mahler.asp. The correlation between the MARS-D
score and the SIMS-D total score showed a low value (r = 0.26)
with statistical signiﬁcance (P < 0.01).
Discriminant Validity
For describing disciminant validity, the results of the two groups
in the test–retest sample are shown: group A for test–retest
patients who had not experienced counseling (n = 15) and group
B for patients who had counseling (n = 15). Preliminary evidence
can be assumed for discriminant validity because SIMS-D scores
in group B improved after medication counseling. Supporting
information can be found in Table 1 at http://www.ispor.org/
Publications/value/ViHsupplementary/ViH12i8_Mahler.asp. It
would be interesting to see whether the total score and subscales
are sensitive to the training of GPs in medication counseling.
Conclusions
In general, the German version of the SIMS shows a reasonably
high return rate, demonstrating the relevance of the issue;
however, older people produce more missing values when ﬁlling
in the questionnaire, which might have an impact on the results
(nonresponder bias). The number of questionnaires without
missing values in Horne’s validation sample is notably higher [5].
The reasons may be patients’ age—patients in our sample were
older—and the fact that our questionnaire was a postal survey, so
patients were not able to have their queries answered. In Horne’s
sample, the patients completed the questionnaire while waiting
on the ward or outpatient clinic; understanding of the question-
naire and approval for participation were veriﬁed on the spot. An
analysis of missing data in the SIMS-D should now be performed
for further development of the instrument.
The psychometric properties of the German version are com-
parable with the original English version [5]. Our results suggest
high internal consistency of the scale and give preliminary evi-
dence for adequate test–retest reliability and discriminate validity
(the test–retest sample was not large enough for a deﬁnitive
conclusion). The overall high values in subscale 1 give evidence
of the face validity of the SIMS-D because GPs mostly commu-
nicate information on usage of medication when counseling
patients [14]. The correlation with questions regarding medica-
tion management in general practice also showed acceptable
values [15]. These items may not appear to contribute signiﬁ-
cantly to the evaluation of criterion validity; however, they
showed if physicians structure medication counseling, drawing
attention to medication-related issues and information. The
positive correlation between the SIMS-D and the MARS-D is
marginal though statistically signiﬁcant. A strong relationship
between satisfaction with information about medicines and
medication adherence, as Horne demonstrated, can therefore not
be explained with our data. Cultural differences in reporting
adherence may be responsible for these differences. We found
substantial ceiling effects that are common in questionnaires
assessing patient satisfaction with their physician [16] and have
also been found in other studies applying the SIMS [8,9].
Our sample represents a typical population of chronically ill
patients in Germany [17,18], although the generalizability of
results may be somewhat limited because of the fact that a
notable proportion of the sample was lost to nonresponse and
incomplete questionnaires. Furthermore, the results may be
biased by motivated physicians voluntarily taking part in the
described project. Nevertheless, preliminary evidence is given
that the SIMS-D measures patient satisfaction with information
about medicines in this group of primary care patients.





















Musculoskeletal diseases (%) 62.5
Diabetes type 2 (%) 54.1
Cardiac insufﬁciency (%) 31.7





Table 2 Descriptive statistics, score distributions (mean, range, median, SD, percentage of ceiling and ﬂoor effects), internal consistency, and interitem
correlation of the SIMS-D (n = 212)





. . . information on “action and usage of
medication” (subscale 1)
6.8 (0–9) 8 2.63 39.6 3.8 0.87 (0.67–0.87) 0.22–0.63
. . . information on “potential problems of
medication” (subscale 2)
4.5 (0–8) 5 3.01 28.8 13.2 0.90 (0.6–0.89) 0.42–0.76
. . . total information received 11.3 (0–17) 12 5.14 25.0 2.8 0.92 (0.85–0.91) 0.13–0.76
SIMS-D, Satisfaction with Information about Medicines Scale, German version.
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Thus, within quality assurance, the SIMS-D could help
target areas in need of improvement in routine care. These
areas could be reaudited at a later point to verify reﬁnement. In
research settings, the SIMS-D could measure the impact of
interventions to improve medication counseling. In clinical
practice and all health-care settings where medication-related
information is essential, the SIMS-D may help plan medication
consultation, and identify and target individual information
deﬁcits of patients. It is hereby important to verify older
patients’ understanding of the questionnaire and willingness to
participate.
Source of ﬁnancial support: AOK Baden-Württemberg—compulsory
health insurance fund. The copyright of the SIMS-D remains with the
originator. Permission to use the SIMS-D must be obtained from Rob
Horne, University of London.
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